These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18219297)

  • 21. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery: a meta-analysis.
    Talati R; Reinhart KM; White CM; Phung OJ; Sedrakyan A; Kluger J; Coleman CI
    Ann Pharmacother; 2009 Jul; 43(7):1181-8. PubMed ID: 19531697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study.
    Covolo L; Gelatti U; Metra M; Nodari S; Piccichè A; Pezzali N; Zani C; Alberti A; Donato F; Nardi G; Dei Cas L
    Eur Heart J; 2004 Sep; 25(17):1534-41. PubMed ID: 15342173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
    Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
    Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta1 and beta2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias.
    Ulucan C; Cetintas V; Tetik A; Eroglu Z; Kayikcioglu M; Can LH; Payzin S; Aydin M; Hasdemir C
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1053-8. PubMed ID: 18479335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario.
    Rochon PA; Anderson GM; Tu JV; Clark JP; Gurwitz JH; Szalai JP; Lau P
    CMAJ; 1999 Nov; 161(11):1403-8. PubMed ID: 10906894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
    Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [389A/G polymorphism of the human beta1-adrenergic receptor in patients with acute myocardial infarction].
    Song YL; Wu XZ; Guo G; Zhang HX; Yang YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):422-4. PubMed ID: 17680533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting beta2-agonists.
    Appleton SL; Ruffin RE; Wilson DH; Taylor AW; Adams RJ;
    J Allergy Clin Immunol; 2009 Jan; 123(1):124-130.e1. PubMed ID: 19130933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tachyphylaxis to beta2-agonists in Spanish asthmatic patients could be modulated by beta2-adrenoceptor gene polymorphisms.
    Tellería JJ; Blanco-Quirós A; Muntión S; Antonio Garrote J; Arranz E; Armentia A; Díez I; Castro J
    Respir Med; 2006 Jun; 100(6):1072-8. PubMed ID: 16263254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The catecholamine-beta-adrenoreceptor-cAMP system and prediction of cardiovascular events in hypertension.
    Peng YX; Shan J; Qi XY; Zhang SJ; Ma SP; Wang N; Li JP; Xue H; Wu M
    Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):227-31. PubMed ID: 16487266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.
    Zaugg M; Bestmann L; Wacker J; Lucchinetti E; Boltres A; Schulz C; Hersberger M; Kälin G; Furrer L; Hofer C; Blumenthal S; Müller A; Zollinger A; Spahn DR; Borgeat A
    Anesthesiology; 2007 Jul; 107(1):33-44. PubMed ID: 17585213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use.
    Dattilo PB; Hailpern SM; Fearon K; Sohal D; Nordin C
    Ann Emerg Med; 2008 Feb; 51(2):117-25. PubMed ID: 17583376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
    Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolving role of β-adrenergic receptor blockers in managing hypertension.
    Poirier L; Lacourcière Y
    Can J Cardiol; 2012 May; 28(3):334-40. PubMed ID: 22595449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of prophylactic beta-blocker therapy to prevent stroke after noncardiac surgery.
    van Lier F; Schouten O; Hoeks SE; van de Ven L; Stolker RJ; Bax JJ; Poldermans D
    Am J Cardiol; 2010 Jan; 105(1):43-7. PubMed ID: 20102888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of chronic beta-blocker use on stroke after noncardiac surgery.
    van Lier F; Schouten O; van Domburg RT; van der Geest PJ; Boersma E; Fleisher LA; Poldermans D
    Am J Cardiol; 2009 Aug; 104(3):429-33. PubMed ID: 19616679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders.
    Lang DM; Alpern MB; Visintainer PF; Smith ST
    Arch Intern Med; 1993 Sep; 153(17):2033-40. PubMed ID: 8102844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.